Back to search

Article

High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa

2022-11-14

Abstract excerpt

<h4>Introduction</h4> Bedaquiline (BDQ) is a lifesaving new tuberculosis (TB) drug undergoing global scale-up. Data on resistance emergence in programmatic settings, especially in patients resistant to other drugs with potentially weak background regimens, is scarce. Such individuals are a priority for novel drug access yet a potential source of population-level resistance. <h4>Methods</h4> We collected culture is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
31f1ed1a-2136-56b4-a2d2-0760d74dbd11
DOI
10.1101/2022.11.14.22282167
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South AfricaDOI 10.1101/2022.11.14.22282167
Select a neighboring publication to make it the new centre.